MedTrace Logo

Safety Study of APD-791 With Aspirin and/or Clopidogrel

NCT02034292 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2019-02-15

No results posted yet for this study

Summary

Evaluating safety and PK parameter of APD-791 when co-administered with aspirin and clopidogrel.

Conditions

  • Acute Coronary Syndrome

Interventions

DRUG

Clopidogrel

DRUG

Aspirin

DRUG

APD791

DRUG

Placebo

Sponsors & Collaborators

  • Asan Medical Center

    collaborator OTHER

  • IlDong Pharmaceutical Co Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-03-31
Completion
2014-03-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02034292 on ClinicalTrials.gov